Alpha Capital Management’s Pfizer PFE Stock Holding History

Alpha Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,626	Closed	-$204K	–	89
2016 Q4	$204K	Hold	6,626	–	–	0.14%	85
2016 Q3	$212K	Buy	+6,626	New	+$222K	0.15%	74
2016 Q1	–	Sell	-6,881	Closed	-$211K	–	81
2015 Q4	$211K	Hold	6,881	–	–	0.17%	67
2015 Q3	$205K	Sell	6,881 -3,241	-32%	-$104K	0.18%	61
2015 Q2	$322K	Buy	10,122 +2,348	+30%	+$76.5K	0.24%	60
2015 Q1	$230K	Hold	7,774	–	–	0.16%	76
2014 Q4	$230K	Buy	7,774 +458	+6%	+$13.1K	0.16%	76
2014 Q3	$205K	Hold	7,316	–	–	0.16%	78
2014 Q2	$206K	Hold	7,316	–	–	0.15%	83
2014 Q1	$223K	Hold	7,316	–	–	0.17%	75
2013 Q4	$213K	Buy	+7,316	New	+$213K	0.17%	72
2013 Q3	–	Sell	-8,077	Closed	-$215K	–	90
2013 Q2	$215K	Buy	+8,077	New	+$223K	0.2%	74

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpha Capital Management's PFE Position: Q1 2017 in Review

Alpha Capital Management sold out of Pfizer (PFE) in Q1 2017, closing a stake of 6,626 shares — an estimated $204K sold.

Alpha Capital Management first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $322K in Q2 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Alpha Capital Management reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
Alpha Capital Management sold 6,626 Pfizer shares in Q1 2017, an estimated $204K.
Alpha Capital Management first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
Alpha Capital Management's Pfizer position peaked at $322K in Q2 2015.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Alpha Capital Management's 13F filing for Q1 2017, filed 25 Apr 2017.